Ledipasvir/sofosbuvir and ribavirin for the treatment of ribavirin-refractory persistent hepatitis E virus infection

Persistent Hepatitis E Virus infection (HEV) is a rare but increasingly recognised condition in immunocompromised individuals. Untreated, this infection can rapidly progress to cirrhosis. Ribavirin is recommended as the first line treatment and the majority achieve sustained viral clearance. However...

Full description

Bibliographic Details

Published in:	IDCases
Main Authors:	Jennifer Gallacher, Yusri Taha, Ana da Silva Filipe, Samreen Ijaz, Stuart McPherson
Format:	Article
Language:	English
Published:	Elsevier 2023-01-01
Subjects:	Hepatitis E virus Treatment Antiviral resistance Chronic infection Immunosuppressed
Online Access:	http://www.sciencedirect.com/science/article/pii/S2214250923000653